Transplanted human ALDHhiCD133+Lin- cells retain primitive hematopoietic surface markers after repopulation in vivo
Transplanted cell population . | CD34+, % . | CD34+CD38+, % . | CD34+CD38-, % . | CD34+CD133+, % . |
---|---|---|---|---|
ALDHhiCD133+Lin- | 30.0 ± 4.7* | 27.4 ± 4.7* | 2.6 ± 0.3† | 6.8 ± 1.1‡ |
CD133+Lin- | 25.3 ± 4.0* | 22.7 ± 3.6* | 2.6 ± 0.6† | 6.1 ± 1.1‡ |
ALDHhiLin- | 14.0 ± 2.6* | 13.8 ± 2.2 | 0.2 ± 0.1 | 1.5 ± 0.6 |
Transplanted cell population . | CD34+, % . | CD34+CD38+, % . | CD34+CD38-, % . | CD34+CD133+, % . |
---|---|---|---|---|
ALDHhiCD133+Lin- | 30.0 ± 4.7* | 27.4 ± 4.7* | 2.6 ± 0.3† | 6.8 ± 1.1‡ |
CD133+Lin- | 25.3 ± 4.0* | 22.7 ± 3.6* | 2.6 ± 0.6† | 6.1 ± 1.1‡ |
ALDHhiLin- | 14.0 ± 2.6* | 13.8 ± 2.2 | 0.2 ± 0.1 | 1.5 ± 0.6 |
Mean expression of primitive cell surface markers after the transplantation of purified ALDHhiCD133+Lin- (n = 6) or CD133+Lin- (n = 5) cells was compared with BM repopulation produced by purified ALDHhiLin- cells (n = 5). Populations that received transplants of ALDHhiCD133+Lin- and CD133+Lin- retained cells that expressed CD34 and showed increased frequencies of CD34+CD38+ progenitors and CD34+CD38- repopulating cells.
P < .05
P < .001
P < .01